[1]
|
De Angelis, R., Sant, M., Coleman, M.P., et al. (2014) Cancer Survival in Europe 1999-2007 by Country and Age: Re-sults of EUROCARE-5—A Population-Based Study. The Lancet Oncology, 15, 23-34.
https://doi.org/10.1016/S1470-2045(13)70546-1
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[3]
|
Allemani, C., Matsuda, T., Di Carlo, V., et al. (2018) Global Surveillance of Trends in Cancer Survival 2000-14 (CONCORD-3): Analysis of Individual Records for 37513025 Patients Diag-nosed with One of 18 Cancers from 322 Population-Based Registries in 71 Countries. The Lancet (London, England), 391, 1023-1075.
https://doi.org/10.1016/S0140-6736(17)33326-3
|
[4]
|
Zeng, H., Chen, W., Zheng, R., et al. (2018) Changing Can-cer Survival in China during 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries. The Lancet Global Health, 6, e555-e567.
https://doi.org/10.1016/S2214-109X(18)30127-X
|
[5]
|
Derry, J.M., Kerns, J.A. and Francke, U. (1995) RBM3, a Novel Human Gene in Xp11.23 with a Putative RNA-Binding Domain. Human Molecular Genetics, 4, 2307-2311. https://doi.org/10.1093/hmg/4.12.2307
|
[6]
|
Zeng, Y., Wodzenski, D., Gao, D., et al. (2013) Stress-Response Pro-tein RBM3 Attenuates the Stem-Like Properties of Prostate Cancer Cells by Interfering with CD44 Variant Splicing. Cancer Research, 73, 4123-4133.
https://doi.org/10.1158/0008-5472.CAN-12-1343
|
[7]
|
Baghdoyan, S., Dubreuil, P., Eberlé, F. and Gomez, S. (2000) Capture of Cytokine-Responsive Genes (NACA and RBM3) Using a Gene Trap Approach. Blood, 95, 3750-3757.
https://doi.org/10.1182/blood.V95.12.3750.012a24_3750_3757
|
[8]
|
Venugopal, A., Subramaniam, D., Balmaceda, J., et al. (2016) RNA Binding Protein RBM3 Increases β-Catenin Signaling to Increase Stem Cell Characteristics in Col-orectal Cancer Cells. Molecular Carcinogenesis, 55, 1503-1516.
https://doi.org/10.1002/mc.22404
|
[9]
|
Sureban, S.M., Ramalingam, S., Natarajan, G., et al. (2008) Translation Regulatory Factor RBM3 Is a Proto-Oncogene That Prevents Mitotic Catastrophe. Oncogene, 27, 4544-4556. https://doi.org/10.1038/onc.2008.97
|
[10]
|
Ehlén, A., Brennan, D.J., Nodin, B., et al. (2010) Expression of the RNA-Binding Protein RBM3 Is Associated with a Favourable Prognosis and Cisplatin Sensitivity in Epithelial Ovarian Cancer. Journal of Translational Medicine, 8, 78.
https://doi.org/10.1186/1479-5876-8-78
|
[11]
|
Boman, K., Segersten, U., Ahlgren, G., et al. (2013) Decreased Ex-pression of RNA-Binding Motif Protein 3 Correlates with Tumour Progression and Poor Prognosis in Urothelial Bladder Cancer. BMC Urology, 13, 17.
https://doi.org/10.1186/1471-2490-13-17
|
[12]
|
Jonsson, L., Bergman, J., Nodin, B., et al. (2011) Low RBM3 Pro-tein Expression Correlates with Tumour Progression and Poor Prognosis in Malignant Melanoma: An Analysis of 215 Cases from the Malmö Diet and Cancer Study. Journal of Translational Medicine, 9, 114. https://doi.org/10.1186/1479-5876-9-114
|
[13]
|
Jonsson, L., Hedner, C., Gaber, A., et al. (2014) High Expression of RNA-Binding Motif Protein 3 in Esophageal and Gastric Adenocarcinoma Correlates with Intestinal Metapla-sia-Associated Tumours and Independently Predicts a Reduced Risk of Recurrence and Death. Biomarker Research, 2, 11. https://doi.org/10.1186/2050-7771-2-11
|
[14]
|
Molina, J.R., Yang, P., Cassivi, S.D., Schild, S. and Adjei, A.A. (2008) Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clinic Proceed-ings, 83, 584-594.
https://doi.org/10.1016/S0025-6196(11)60735-0
|
[15]
|
Tas, F., Ciftci, R., Kilic, L. and Karabulut, S. (2013) Age Is a Prognostic Factor Affecting Survival in Lung Cancer Patients. Oncology Letters, 6, 1507-1513. https://doi.org/10.3892/ol.2013.1566
|
[16]
|
王瑞, 赵佳, 张龙. 肺腺癌患者肺组织中RBM3 mRNA表达及意义[J]. 临床肺科杂志, 2019, 24(12): 2236-2240.
|
[17]
|
Zhou, R.B., Lu, X.L., Zhang, C.Y. and Yin, D.C. (2017) RNA Binding Motif Protein 3: A Potential Biomarker in Cancer and Therapeutic Target in Neuroprotection. Oncotarget, 8, 22235-22250.
https://doi.org/10.18632/oncotarget.14755
|
[18]
|
Jögi, A., Brennan, D., Rydén, L., et al. (2009) Nuclear Expression of the RNA-Binding Protein RBM3 Is Associated with an Improved Clinical Outcome in Breast Cancer. Modern Pa-thology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, 22, 1564-1574. https://doi.org/10.1038/modpathol.2009.124
|
[19]
|
Ehlén, Å., Nodin, B., Rexhepaj, E., et al. (2011) RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer. Translation-al Oncology, 4, 212-221. https://doi.org/10.1593/tlo.11106
|
[20]
|
O’Connell, R.M., Rao, D.S., Chaudhuri, A.A. and Baltimore, D. (2010) Physiological and Pathological Roles for microRNAs in the Immune System. Nature Reviews Im-munology, 10, 111-122. https://doi.org/10.1038/nri2708
|
[21]
|
Jonsson, L., Gaber, A., Ulmert, D., et al. (2011) High RBM3 Expression in Prostate Cancer Independently Predicts a Reduced Risk of Biochemical Recurrence and Disease Progression. Diagnostic Pathology, 6, 91.
https://doi.org/10.1186/1746-1596-6-91
|
[22]
|
Yang, G., Fu, H., Zhang, J., et al. (2010) RNA-Binding Protein Quaking, a Critical Regulator of Colon Epithelial Differentiation and a Suppressor of Colon Cancer. Gastroenterology, 138, 231-240.e231-235.
https://doi.org/10.1053/j.gastro.2009.08.001
|
[23]
|
Schneider, J., Gómez-Esquer, F., Díaz-Gil, G., Torrejón, R. and Pollán, M. (2011) mRNA Expression of the Putative Antimetastatic Gene BRMS1 and of Apoptosis-Related Genes in Breast Cancer. Cancer Genomics & Proteomics, 8, 195-197.
|
[24]
|
Ye, F., Jin, P., Cai, X., Cai, P. and Cai, H. (2017) High RNA-Binding Motif Protein 3 (RBM3) Expression Is Independently Associated with Prolonged Overall Survival in Intestinal-Type Gastric Cancer. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 23, 6033-6041.
https://doi.org/10.12659/MSM.905314
|
[25]
|
曾丹, 华金仁, 安云婷. RBM3在卵巢上皮性癌中的表达及临床意义[J]. 当代医学, 2016, 22(31): 14-15.
|
[26]
|
Zhang, H.T., Zhang, Z.W., Xue, J.H., Kong, H.B., Liu, A.J., Li, S.C., et al. (2013) Differential Expression of the RNA-Binding Motif Protein 3 in Human Astrocytoma. Chinese Medical Journal, 126, 1948-1952.
|
[27]
|
Ma, R., Zhao, L.N., Yang, H., et al. (2018) RNA Binding Motif Protein 3 (RBM3) Drives Radi-oresistance in Nasopharyngeal Carcinoma by Reducing Apoptosis via the PI3K/AKT/Bcl-2 Signaling Pathway. American Journal of Translational Research, 10, 4130-4140.
|
[28]
|
郭俊杰, 李锁严, 董丽艳, 于伟杰, 刘翠萍, 韩明玥. 浸润性乳腺癌组织中RNA结合基序蛋白3的表达水平及意义[J]. 癌症进展, 2019, 17(12): 1449-1452.
|
[29]
|
Grupp, K., Hofmann, B., Kutup, A., et al. (2018) Reduced RBM3 Expression Is Associated with Aggressive Tumor Features in Esophageal Cancer but Not Significantly Linked to Patient Outcome. BMC Cancer, 18, 1106.
https://doi.org/10.1186/s12885-018-5032-z
|